3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow AUT00063: new trials by email Literature Review of AUT00063 trials Research Report on AUT00063
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating Possible Improvement in Speech and Hearing Tests After 28 Days of Dosing of the Study Drug AUT00063 Compared to Placebo (QuicKfire) AUT00063, Placebo - Hearing Loss, Hearing Impairment | Phase 2 | Completed | Autifony Therapeutics Limited | 15 | 2016-05-01 | 2017-05-24 |
| Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss AUT00063, Placebo - Age-Related Hearing Loss | Phase 2 | Completed | Autifony Therapeutics Limited | 78 | 2015-01-01 | 2018-08-09 |
| Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo AUT00063, Placebo - Tinnitus, Subjective | Phase 2 | Completed | Autifony Therapeutics Limited | 91 | 2014-10-01 | 2016-03-31 |
Hearing Loss (2) · Presbycusis (1) · Tinnitus (1)
Autifony Therapeutics Limited (3)
United Kingdom (2) · United States (1)
Jaydip Ray, MD (1) · Robert Frisina, PhD (1) · Shakeel R Saeed, MD, FRCS (ORL) (1)
2015 (1)